HealthTech.euabout 1 hour ago
Vitroscope Raises $7M for Living Tissue Tech
2 min read
Vitroscope, a biotech firm developing perfusion platforms for drug discovery, raised $7 million total. This includes a $5 million seed round led by Cerberus Ventures and YZR Capital, plus $2 million in non-dilutive funding from the Research Council of Norway. The company now has $8.8 million to date.
Level
Hype check
Tap to vote and see what everyone thinks.
